AHL Partners LLP - PROGENICS PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 154 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2017. The put-call ratio across all filers is 1.56 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
AHL Partners LLP ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2017$147,000–19,919–0.00%–
 Download
Other shareholders

There were no reported owners of PROGENICS PHARMACEUTICALS IN in Q4 2017.

NameSharesValueWeighting ↓
View complete list of PROGENICS PHARMACEUTICALS IN shareholders